Clinical Trial

The Characteristics of Gut Microbiota in Patients With Sarcopenia and the Development of Probiotics

Recruiting
View on ClinicalTrials.gov →
Summary
The primary aim of this study is to identify the composition and characteristics of the gut microbiota in patients with sarcopenia in older adults, and compare these with the gut microbiota characteristics of older adults and young control groups to determine differences. Secondary purpose of this study is to provide data on the characteristics of gut microbiota for the development of probiotics effective in treating sarcopenia in older adults.
Trial Details
NCT Number NCT07334210
Lead Sponsor Seoul National University Bundang Hospital
Conditions Sarcopenia
Enrollment 150 participants
Start Date 2025-06-13
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-12